FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319004803> ?p ?o ?g. }

• W4319004803 abstract "Introduction: The modified Rankin Scale (mRS) is a disability outcome measure often utilized in mechanical thrombectomy (MT) trials. An mRS of 0-2 at 90 days post intervention has been deemed a good functional outcome. Some trials required a pre-stroke mRS 0-1, while others included patients in the 0-2 range. None of the major trials enrolled patients with baseline mRS greater than 2, and there have been limited data/review of outcomes in these patients with inconclusive results. We conducted an institutional retrospective review to evaluate the proportion of patients who underwent successful MT (TICI 2b or higher) and remained at their baseline mRS. This will enable us to more appropriately evaluate if patients with higher baseline mRS should be considered for intervention. Methods: We conducted a retrospective review of all patients who underwent successful MT at our institution through 2021. Utilizing descriptive statistics in SAS, we specifically evaluated the number of patients who remained at their baseline mRS post intervention at each level. Results: 412 patients were included (259 patients with mRS 0, 66 with mRS 1, 36 with mRS 2, 29 with mRS 3, 16 with mRS 4, and 6 with mRS 5). Of the 412, 60 patients remained at their pre-stroke mRS at 90-days post intervention (14.29 % at mRS 0, 15.15% at 1, 16.67% at 2, 17.24% at 5, 0% at 4, and 33.33% at 5). Conclusion: Our data suggests that patients with higher baseline mRS, specifically mRS 3, may benefit from intervention with MT to maintain their functional ability. The proportion of patients who remained at their pre-stroke mRS was higher in the subgroup with mRS 3 comparative to mRS of 0 or 1; however, there were fewer patients overall. Our institutional data also highlights that patients with baseline mRS 3 did similarly well in maintaining their premorbid functional ability as those with mRS 2 (36 vs 29 patients, 17% in each group). This ultimately suggests that patients with baseline mRS 3 should be considered for MT. There are too few patients with baseline mRS 4 and 5 in our study, and given there is already significant disability in these subgroups, it would be difficult to conclude currently that these patients should undergo intervention." @default.
• W4319004803 created "2023-02-03" @default.
• W4319004803 creator A5005027485 @default.
• W4319004803 creator A5007044838 @default.
• W4319004803 creator A5010042773 @default.
• W4319004803 creator A5056006632 @default.
• W4319004803 creator A5069392620 @default.
• W4319004803 creator A5071593369 @default.
• W4319004803 creator A5074654320 @default.
• W4319004803 creator A5075075470 @default.
• W4319004803 creator A5079585504 @default.
• W4319004803 date "2023-02-01" @default.
• W4319004803 modified "2023-09-27" @default.
• W4319004803 title "Abstract TP136: Thrombectomy Outcomes In Patients With Elevated Modified Rankin Scores" @default.
• W4319004803 doi "https://doi.org/10.1161/str.54.suppl_1.tp136" @default.
• W4319004803 hasPublicationYear "2023" @default.
• W4319004803 type Work @default.
• W4319004803 citedByCount "0" @default.
• W4319004803 crossrefType "journal-article" @default.
• W4319004803 hasAuthorship W4319004803A5005027485 @default.
• W4319004803 hasAuthorship W4319004803A5007044838 @default.
• W4319004803 hasAuthorship W4319004803A5010042773 @default.
• W4319004803 hasAuthorship W4319004803A5056006632 @default.
• W4319004803 hasAuthorship W4319004803A5069392620 @default.
• W4319004803 hasAuthorship W4319004803A5071593369 @default.
• W4319004803 hasAuthorship W4319004803A5074654320 @default.
• W4319004803 hasAuthorship W4319004803A5075075470 @default.
• W4319004803 hasAuthorship W4319004803A5079585504 @default.
• W4319004803 hasConcept C118552586 @default.
• W4319004803 hasConcept C126322002 @default.
• W4319004803 hasConcept C127413603 @default.
• W4319004803 hasConcept C167135981 @default.
• W4319004803 hasConcept C1862650 @default.
• W4319004803 hasConcept C2780645631 @default.
• W4319004803 hasConcept C2780665704 @default.
• W4319004803 hasConcept C2780931571 @default.
• W4319004803 hasConcept C3020199598 @default.
• W4319004803 hasConcept C535046627 @default.
• W4319004803 hasConcept C541997718 @default.
• W4319004803 hasConcept C71924100 @default.
• W4319004803 hasConcept C78519656 @default.
• W4319004803 hasConceptScore W4319004803C118552586 @default.
• W4319004803 hasConceptScore W4319004803C126322002 @default.
• W4319004803 hasConceptScore W4319004803C127413603 @default.
• W4319004803 hasConceptScore W4319004803C167135981 @default.
• W4319004803 hasConceptScore W4319004803C1862650 @default.
• W4319004803 hasConceptScore W4319004803C2780645631 @default.
• W4319004803 hasConceptScore W4319004803C2780665704 @default.
• W4319004803 hasConceptScore W4319004803C2780931571 @default.
• W4319004803 hasConceptScore W4319004803C3020199598 @default.
• W4319004803 hasConceptScore W4319004803C535046627 @default.
• W4319004803 hasConceptScore W4319004803C541997718 @default.
• W4319004803 hasConceptScore W4319004803C71924100 @default.
• W4319004803 hasConceptScore W4319004803C78519656 @default.
• W4319004803 hasIssue "Suppl_1" @default.
• W4319004803 hasLocation W43190048031 @default.
• W4319004803 hasOpenAccess W4319004803 @default.
• W4319004803 hasPrimaryLocation W43190048031 @default.
• W4319004803 hasRelatedWork W1977024809 @default.
• W4319004803 hasRelatedWork W2105151527 @default.
• W4319004803 hasRelatedWork W2363255808 @default.
• W4319004803 hasRelatedWork W3009852707 @default.
• W4319004803 hasRelatedWork W3013145321 @default.
• W4319004803 hasRelatedWork W3095141535 @default.
• W4319004803 hasRelatedWork W3187162938 @default.
• W4319004803 hasRelatedWork W3208090289 @default.
• W4319004803 hasRelatedWork W3210359220 @default.
• W4319004803 hasRelatedWork W4255376461 @default.
• W4319004803 hasVolume "54" @default.
• W4319004803 isParatext "false" @default.
• W4319004803 isRetracted "false" @default.
• W4319004803 workType "article" @default.